Nutra Pharma Corp., a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has announced today that nationally distributed Reptiles Magazine has published a feature article by Nutra Pharma Chairman and CEO, Rik J Deitsch.
“It is important to educate the public about snakes and their contributions to society throughout history,” explained Rik J Deitsch, Chairman of Nutra Pharma Corporation. “The purpose of this article is to examine the historical and modern significance of snakes in medicine and the use of snake venom in modern-day drug discovery,” he concluded.
The article, entitled Snakes in Medicine: From the Greeks to the FDA, is available in the March 2007 issue of Reptiles Magazine.
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Nutra Pharma's ("the Company") business plan. The Company's business is subject to various risks, which are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"). The publication of the article by Rik J. Deitsch in Reptiles Magazine should not be construed as an indication in any way whatsoever of the value of the Company or its common stock. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.